Friday, September 3, 2010
"The source for European pharmaceutical biotechnology news..."
Sponsors
Platinum Sponsors
Blog
Where our team of editors discuss what they think about the current NGP US Issues.
Marie Shields
Editor NGP Europe
Editor NGP Europe
Tough competition
The battle between generics and branded products has been going on for a long time: the claims and counter claims over Aspirin, for example, have been in process since the early 20th century.06 Aug 2009
White Papers
Focus Areas
Cover Stories
The freedom to dream
Boehringer Ingelheim's Andreas Barner believes in allowing his researchers the space to follow their inspiration. The result has been three...
Leaping the hurdles
As patents expire and pipelines are pressured, NGP finds out how Lundbeck's Peter Hongaard Andersen is working to stay at the cutting edge of...
Sweet medicine
For people with diabetes a lack of insulin means regulating the body's blood sugar levels is a challenge. As the prevalence of the disease...
Roundtables
-
Outsourcing the problem
NGP gathers some of the industry’s leading experts to discuss the growing relationship between pharmaceutical companies and the outsourcing space.Read more -
A world of discovery
NGP gathers four industry experts to discuss the current drug development space.Read more -
Supply chain optimisation
A panel of experts share their opinions on the challenges and benefits of an efficient supply chain.Read more -
The challenges of biopharmaceutical manufa...
With Michel Pautrat of Creapharm, Robert J. Broeze of Laureate Pharma, Jens Torkel of Oystar, Torbjörn Gunnarsson of Nordvalls and John Pirro of Synomics Pharma.Read more
Vendor Perspectives
-
Multiplex testing through Biochip Array ...
Biochip Array Technology adds an extra option to diagnostic testing, whether for routine immunoassays, research, clinical trials or DNA screening. By Randox LaboratoriesRead more -
The innovators of miniature spectroscopy...
Recognised as the inventor of miniature spectroscopy, Ocean Optics is always looking to expand the frontiers of optical sensing and make it the foundation on which...Read more
Industry Analysts
-
Improving patient safety
Could patient safety be further improved by enhancing the readability testing process for PILs, labels, sleevers and extending this to cover packaging and design? By Brian...Read more -
Risk mitigation and improved predictabilit...
By Ulf DanielssonRead more
Executive Interviews
Creating business advantages
Mike Harrington of Waters Corporation looks at the company’s approach to new technology development.
Read more
Lab partners
NGP speaks with Willem van Leeuwen of QMR Technology about the benefit of teaming with a specialist IT provider for clinical trials.
Read more
NGP Europe Summit: Drug Discovery
1st - 3rd September 2010
The Next Generation Drug Discovery Summit Europe is designed to bridge the growing technological gap between drug discovery and drug development.
Source: www.ngpharma.eu.com© 2010 GDS Publishing Ltd. All rights reserved.